Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice

Clinical and Experimental Immunology

Volumn 153, Issue 2, 2008, Pages 269-276

  Choi, J J ^a   Yoo, S A ^b   Park, S J ^b   Kang, Y J ^c   Kim, W U ^b   Oh, I H ^c   Cho, C S ^b,d  

^a CHA University   (South Korea)

^b ST MARY S HOSPITAL   (United States)

^c The Catholic University of Korea   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

IL 10; Mesenchymal stem cells; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 2; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DBA 1 MOUSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PANNUS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL PROLIFERATION; COLLAGEN TYPE II; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VECTORS; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED DBA; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 47249155734     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03683.x     Document Type: Article

References (37)

1. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999 284:143 7.
2. Ferrari G, Cusella-De Angelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998 279:1528 30.
3. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005 308:1472 7.
4. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997 276:71 4.
5. Petite H, Viateau V, Bensaid W et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000 18:959 63.
6. Reyes M, Lund T, Lenvik T, Aquiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001 98:2615 25.
7. Jorgensen C, Djouad F, Apparailly F, Noel D. Engineering mesenchymal stem cells for immunotherapy. Gene Ther 2003 10:928 31.
8. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998 160:5213 20.
9. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99:3838 43.
10. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 102:3837 44.
11. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004 363:1439 41.
12. Miossec P, van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum 1997 40:2105 15.
13. Isomaki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996 39:386 95.
14. Cohen SB, Katsikis PD, Chu CQ et al. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 1995 38:946 52.
15. Finnegan A, Kaplan CD, Cao Y, Eibel H, Glant TT, Zhang J. Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res Ther 2003 5:R18 24.
16. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994 179:1517 27.
17. Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 1997 27:1451 8.
18. Joosten LA, Lubberts E, Durez P et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Arthritis Rheum 1997 40:249 60.
19. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991 174:1549 55.
20. Kuroda T, Maruyama H, Shimotori M et al. Effects of viral interleukin 10 introduced by in vivo electroporation on arthrogen-induced arthritis in mice. J Rheumatol 2006 33:455 62.
21. van Roon JA, van Roy JL, Gmelig-Meyling FH et al. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996 39:829 35.
22. Min CK, Kim BG, Park G, Cho B, Oh IH. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant 2007 39:637 45.
23. Kang YJ, Yang SJ, Park G et al. A novel function of interleukin-10 promoting self-renewal of hematopoietic stem cells. Stem Cells 2007 25:1814 22.
24. Yoo SA, Bae DG, Ryoo JW et al. Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes. J Immunol 2005 174:5846 55.
25. Kim WU, Lee WK, Ryoo JW et al. Suppression of collagen-induced arthritis by single administration of poly (lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. Arthritis Rheum 2002 46:1109 20.
26. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002 30:42 8.
27. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005 305:33 41.
28. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105:1815 22.
29. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005 105:2821 7.
30. Haniffa MA, Wang XN, Holtick U et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007 179:1595 604.
31. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996 39:495 503.
32. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995 95:2868 76.
33. Ma Y, Thornton S, Duwel LE et al. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J Immunol 1998 161:1516 24.
34. Kim KN, Watanabe S, Ma Y, Thornton S, Giannini EH, Hirsch R. Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer. J Immunol 2000 164:1576 81.
35. Djouad F, Fritz V, Apparailly F et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005 52:1595 603.
36. Tilg H, Ulmer H, Kaser A, Weiss G. Role of IL-10 for induction of anemia during inflammation. J Immunol 2002 169:2204 9.
37. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007 56:1175 86.